Polyethylene Glycol Excipients Excipient Use in Suspension Extended Release Dosage Forms

Polyethylene Glycol Excipients

DESCRIPTION

DESCRIPTION

Suppliers

17 Listed Products, 2 Nomisma Healthcare, 3 Actylis, 2 Seqens, 1 Gangwal Chemicals, 8 BASF, 1 Finar

REGULATORY FILINGS

5 Suppliers, 4 USDMF, 1 JDMF

SOLUTIONS BY APPLICATIONS

7 Topical, 4 Thickeners and Stabilizers, 4 Controlled & Modified Release, 4 Solubilizers, 2 Parenteral, 1 Film Formers & Plasticizers, 1 Granulation, 1 Coating Systems & Additives

REF. STANDARDS & IMPURITIES

10 Others

10 Others

FINISHED FORMULATIONS

1194 ORAL, 825 TABLET, 211 TABLET, EXTENDED RELEASE, 62 CAPSULE, 30 CAPSULE, EXTENDED RELEASE, 23 TABLET, DELAYED RELEASE, 13 SOLUTION, 12 CAPSULE, DELAYED REL PELLETS, 12 TOPICAL, 10 ORAL-28, 9 OINTMENT, 8 FOR SUSPENSION, 5 CAPSULE, DELAYED RELEASE, 4 FILM, 4 TABLET, CHEWABLE, 4 TABLET, ORALLY DISINTEGRATING, 3 BUCCAL, SUBLINGUAL, 3 INTRAVENOUS, 3 SUSPENSION, 3 VAGINAL, 2 EMULSION, 2 GRANULE, 2 ORAL-21, 2 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE, 1 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, 1 CONCENTRATE, 1 CREAM, 1 FOR SOLUTION, 1 FOR SUSPENSION, DELAYED RELEASE, 1 IM-IV, 1 INJECTABLE, 1 INJECTION, 1 INSERT, EXTENDED RELEASE, 1 INTRAUTERINE, 1 SUSPENSION, EXTENDED RELEASE, 1 SYRUP, 1 SYSTEM, 1 TABLET, COATED PARTICLES